MiTiHeart™ Left Ventricular Assist Device (LVAD) uses a uniquely designed magnetic levitation system to eliminate the need for any mechanical contact bearings or contamination from lubricants. Since 1995, Mohawk Innovative Technology, Inc, (MiTi^®) has been developing this unique blood pump with funding from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) for bridge-to-transplant and destination therapy (or long-term implant) for patients suffering from end stage congestive heart failure.

Principal Features and Benefits:

• One simple moving component
• A simple, yet elegant rotor, magnetically levitated in blood
• Energy efficient and low power consumption
• Long-life, lightweight, wearable battery system (under development)
• Extremely low levels of blood damage due to the pump's unique design
• Unaffected by external shock and vibrations
• Very low production cost due to simple design

| Home Page | Technology | Technical Details | Technical Specifications | History of Development | Pre-Clinical Testing | Our Company | Biography | Management | Present & Potential Market | News Room | Patents & Publications | Exhibits | Contact Us | Site Map | Useful Sites |

Copyright 2006 © MiTiHeart Corporation. All Rights Reserved.

A Subsidiary of Mohawk Innovative Technology, Inc.